The table below shows AtriCure, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$4.00M
-$11.03M
-$21.02M
-$4.08M
-$24.63M
-$9.32M
Capital expenditure
$3.85M
$2.18M
$2.77M
$2.50M
$3.38M
$1.33M
Investing cash flow
-$3.85M
-$1.68M
$9.64M
$28.81M
$19.72M
$63.59M
Dividends paid
-
-
-
-
ATRC operating cash flow (10-K history)
AtriCure, Inc. reported operating cash flow of $57.33M for fiscal year 2025. That is up 369.8% from $12.20M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$15.12M (FY 2016) to $57.33M. Figures come from the company's audited annual reports as filed with the SEC.